Cynosure (CYNO) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/2/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results
July 27, 2016 10:58 AM EDTBrean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following the company's 2Q earnings report. Revenue was $110.3 million vs. consensus of $101.3 million. The growth was driven primarily by product expansion in North America. Non-GAAP EPS came in... More
Northland Capital Markets Raises Price Target on Cynosure (CYNO) to $60 Following 2Q
July 27, 2016 10:41 AM EDTNorthland Capital Markets reiterated an Outperform rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. CYNO reported revenues of $110M, coming in ahead of the Street's $102M estimates. EPS of $0.27 was also above estimates.... More
Cynosure (CYNO) PT Raised to $62 at Stifel
July 26, 2016 2:06 PM EDTStifel analyst Jonathan Block reiterated a Buy rating and lifted his price target on Cynosure (NASDAQ: CYNO) to $62.00 (from $57.00) following solid Q2 results. The analyst is looking for margin expansion in 2017.
Block commented, "The quarter was solid with top-line ahead of... More

